Hong Kong Transportation Stock News

Why Newborn Town’s Updated Revenue Guidance Matters Now Newborn Town (SEHK:9911) issued new revenue guidance for the six months to 30 June 2026, flagging expected group revenue of about US$595 million to US$615 million, an increase of roughly 34.3% to 38.8% year on year. The company linked this expected range to combined contributions from its social networking business and its other newer business lines, which keeps attention on how these segments shape the stock’s appeal for investors. See...

In recent months, the Asian markets have been marked by a mix of volatility and opportunity, driven in part by global economic shifts and technological advancements. As investors navigate this landscape, growth companies with high insider ownership are particularly appealing due to their potential for strong alignment between management and shareholder interests.

As the Asian markets continue to navigate a complex landscape marked by fluctuating economic indicators and evolving market sentiment, small-cap stocks have emerged as intriguing opportunities for investors seeking growth potential. In this dynamic environment, identifying promising small-cap stocks involves assessing factors such as innovative business models, strong financial health, and adaptability to changing economic conditions.

Envision Greenwise Holdings Limited ( HKG:1783 ) announced strong profits, but the stock was stagnant. We did some...

InSilico Medicine Cayman TopCo (SEHK:3696) received FDA Fast Track Designation for ISM6331, an AI-generated pan-TEAD inhibitor for malignant pleural mesothelioma. The company secured NMPA IND approval for ISM8969/HT-001, a BBB-penetrant NLRP3 inhibitor for neuroinflammatory diseases such as Parkinson's, enabling parallel trials in China and Australia. InSilico Medicine Cayman TopCo launched a Drug Discovery and Development Benchmarks as a Service platform to measure AI and foundation model...

BYD stock has picked up recently after a weak 12 month stretch, yet the valuation checks and current market multiples still point to a mixed picture rather than a clear bargain or clear overvaluation. BYD shares are down 16.7% over the past year, which puts recent gains into context and raises the question of whether the current price fairly reflects the business outlook. Recent news on rising new energy vehicle sales and product launches can support expectations for future growth. The risk...

China Everbright (SEHK:165) has warned investors of a sharp earnings setback. The company expects profit attributable to shareholders for the first half of 2026 to be 70% to 80% lower than the HK$399 million reported a year earlier. See our latest analysis for China Everbright. China Everbright's latest earnings warning lands after a mixed share price pattern, with a 10.66% 1 month share price return contrasting with a year to date share price decline of 36.05% and a 1 year total shareholder...

Shareholders appeared unconcerned with Chen Hsong Holdings Limited's ( HKG:57 ) lackluster earnings report last week...

Global exchange operators are in the spotlight after Hong Kong launched five-year Chinese treasury bond futures, a move that could reshape how global investors manage interest rate risk in offshore yuan markets. With new tools sitting alongside Bond Connect and Swap Connect, attention is turning to which listed exchanges might see meaningful shifts in activity as investors reassess Chinese bonds and the role of the renminbi. This article covers three stocks from our Global Exchange Operators...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Insiders at Realord Technology Company Limited ( HKG:1196 ) sold HK$421m worth of stock at an average price of HK$3.83...

Half year results and dividend in focus Hang Lung Properties (SEHK:101) has drawn investor attention after reporting half year results that showed higher sales but lower net income, along with an affirmed interim dividend of HK$0.12 per share. See our latest analysis for Hang Lung Properties. The latest half year announcement and dividend affirmation come after a mixed price pattern for Hang Lung Properties, with a 1 month share price return of 5.98% but a 90 day share price decline of...

It's been a good week for Hang Lung Properties Limited ( HKG:101 ) shareholders, because the company has just released...

TVB Limited ( HKG:511 ), is not the largest company out there, but it received a lot of attention from a substantial...

Air China (SEHK:753) has drawn fresh attention after agreeing to purchase 15 Airbus A350-900 and 40 Airbus A320NEO series aircraft, a fleet expansion that directly affects capacity planning and long term capital commitments. See our latest analysis for Air China. The Airbus purchase agreements land at a time when Air China’s share price has been under pressure, with the stock at HK$4.31 and a year to date share price decline of 39.38% alongside a 1 year total shareholder return decline of...

Kingboard Laminates Holdings (SEHK:1888) issued new unaudited earnings guidance for the six months to June 30, 2026, flagging net profit of more than HK$2.8b, over 200% higher than a year earlier. See our latest analysis for Kingboard Laminates Holdings. At a share price of HK$30.0, Kingboard Laminates Holdings has a 1 day share price return of 1.97% but a 30 day share price return that is down 64.48%. The 1 year total shareholder return of 190.19% and 3 year total shareholder return of over...

Tencent Holdings (SEHK:700) has drawn fresh attention after launching Digital Jingdezhen, an AI-powered cultural heritage game, and supporting tapmad’s streaming of a major global football tournament through Tencent Cloud services. See our latest analysis for Tencent Holdings. The recent product launches and cloud wins sit against a mixed performance picture for Tencent Holdings, with the share price at HK$490.4 after a 1-month share price return of 13.73% but a year-to-date share price...

Ascletis Pharma recently reported that its next-generation triple peptide agonist ASC37 achieved greater weight loss than tirzepatide in diet‑induced obese mice, and outlined plans to file investigational new drug applications for both once‑monthly subcutaneous and oral formulations in the third quarter of 2026. The company also highlighted that ASC37 and its dual agonist ASC35 qualify as biologics, potentially benefiting from longer U.S. exclusivity and reduced exposure to government price...

ASMPT Limited recently reported past second-quarter 2026 results showing sales of HK$4,935.8 million and net income of HK$335.14 million, both higher than a year earlier, alongside stronger basic earnings per share from continuing operations of HK$1.01. The company also announced a leadership transition effective August 11, 2026, with long-serving Group CEO Robin Gerard Ng Cher Tat retiring and semiconductor veteran Bassel Haddad stepping in as the new Group CEO and Executive Director,...

China XLX Fertiliser (SEHK:1866) drew fresh attention after issuing earnings guidance for the first half of 2026, flagging a 52% to 62% year-on-year rise in net profit to about RMB 1.15b to RMB 1.23b. See our latest analysis for China XLX Fertiliser. The earnings guidance arrives after a sharp change in sentiment around China XLX Fertiliser, with the share price at HK$9.215 and a 30 day share price return of 6.66% contrasting with a 90 day decline of 27.61%. At the same time, the 1 year total...

The launch of 5 year China government bond futures in Hong Kong has put fresh attention on stocks that run exchanges and trading platforms linked to Chinese markets. Global asset managers, pension funds, and insurers are watching how this new offshore tool could affect liquidity, hedging, and cross border capital flows. For you as a retail investor, the real question is which exchange operators might stand to benefit if international interest in Chinese bonds continues to build. This article...

Akeso (SEHK:9926) is back in focus after dosing the first patient in a Phase Ib/II trial of its HER3 antibody drug conjugate AK138D1 for advanced non small cell lung cancer. See our latest analysis for Akeso. Akeso’s latest trial milestone comes after a period where sentiment has cooled, with the share price at HK$91.95 and the 1-year total shareholder return down 39.55%, although the 3-year total shareholder return remains very strong. If Akeso’s oncology work has caught your attention, this...

Zhaojin Mining Industry (SEHK:1818) has announced a reshuffle in senior leadership, with President Wang Leyi and Authorised Representative Duan Lei stepping down and Li Guanghui moving into the roles of President and Authorised Representative. See our latest analysis for Zhaojin Mining Industry. The leadership reshuffle comes at a time when Zhaojin Mining Industry’s share price has recovered in the short term, with a 1 month share price return of 10.59%, although the share price is still down...

China and Hong Kong are back in focus as policy support, AI investment and fiscal spending reshape expectations for infrastructure and industrial upgrade beneficiaries. Fresh capital is circling around projects tied to government-backed investment, while the Hong Kong market is seeing renewed interest in internet platforms, healthcare, finance and high-dividend stocks. At the same time, higher for longer US rates and energy risks are keeping risk management front and center. This article...